Results 71 to 80 of about 1,282 (161)

Effects of intravenous ketamine in a patient with post-treatment Lyme disease syndrome

International Medical Case Reports Journal, 2017
Ashraf F Hanna, Bishoy Abraham, Andrew Hanna, Adam J Smith Department of Pain Management, Florida Spine Institute, Clearwater, FL, USA Abstract: Post-treatment Lyme disease syndrome (PTLDS) is a pain disorder for which there remains no ...
Hanna AF, Abraham B, Hanna A, Smith AJ
doaj  

Combining Double-Dose and High-Dose Pulsed Dapsone Combination Therapy for Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome and Co-Infections, Including Bartonella: A Report of 3 Cases and a Literature Review

Microorganisms
Three patients with relapsing and remitting borreliosis, babesiosis, and bartonellosis, despite extended anti-infective therapy, were prescribed double-dose dapsone combination therapy (DDDCT) for 8 weeks, followed by one or several two-week courses of ...
Richard I. Horowitz, John Fallon, Phyllis R. Freeman   +2 more
doaj   +1 more source

Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library

Emerging Microbes and Infections, 2014
Although antibiotic treatment for Lyme disease is effective in the majority of cases, especially during the early phase of the disease, a minority of patients suffer from post-treatment Lyme disease syndrome (PTLDS).
Jie Feng, Ting Wang, Wanliang Shi, Shuo Zhang, David Sullivan, Paul G Auwaerter, Ying Zhang   +6 more
doaj   +1 more source

EBV-DNA E MODULAZIONE DELL’IMMUNO-SOPPRESSIONE NEL CONTROLLO DELLE PTLDs POST TRAPIANTO DI FEGATO PEDIATRICO

Microbiologia Medica, 2006
-
A. Callegaro, F. Nozza, P. Stroppa, G. Torre, A. Goglio   +4 more
doaj   +1 more source

Biomarker-Based Analysis of Pain in Patients with Tick-Borne Infections before and after Antibiotic Treatment

Antibiotics
Tick-borne illnesses (TBIs), especially those caused by Borrelia, are increasingly prevalent worldwide. These diseases progress through stages of initial localization, early spread, and late dissemination.
Kunal Garg, Abbie Thoma, Gordana Avramovic, Leona Gilbert, Marc Shawky, Minha Rajput Ray, John Shearer Lambert   +6 more
doaj   +1 more source

Preventing PTLD? [PDF]

American Journal of Transplantation, 2018
openaire   +1 more source

DP010 | POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: MULTICENTER OBSERVATIONAL RETROSPECTIVE COHORT STUDY OF THE ITALIAN LYMPHOMA FOUNDATION

Haematologica
Background and Aims. Post-transplant lymphoproliferative disorders (PTLDs) are rare complications occurring either after solid organ (SOT) or hematopoietic stem cell (HSCT) transplantation, with an overall incidence of about 1% at 10 years.
C. Consoli, P. Minga, P.L. Zinzani, A. Ferreri, F.G. Rossi, A. Castellino, M. Spina, R. Bruna, L. Petrucci, L. Arcaini, A.M. Barbui, B. Botto, E. Cencini, S. Hohaus, D. Marino, J. Olivieri, B. Puccini, A. Re, O. Annibali, M. Riva, A. Tafuri, S.V. Usai, A. Evangelista, B. Bruno, F. Cavallo   +24 more
doaj  

Quantifying the Public Health Impact of Lyme Disease in Minnesota: A Simulation Analysis of Reported and Unreported Cases. [PDF]

J Health Econ Outcomes Res
Angell KE, Broadhurst MJ, Dong JJ, Michaud TL, Degarege A, Cortinas R, Brett-Major DM.   +6 more
europepmc   +1 more source

Reassessing Chronic Lyme Disease and Post-Treatment Lyme Disease Syndrome as Focal Infections. [PDF]

Cureus
Lakos A, Nagy G, Varga Z, Rásonyi-Kovács P, Hornok S.   +4 more
europepmc   +1 more source

Nonspecific Symptoms Attributable to Lyme Disease in High-Incidence Areas, United States, 2017-2021. [PDF]

Emerg Infect Dis
Nawrocki CC, Delorey MJ, Earley AR, Hook SA, Kugeler KJ, Marx GE, Mead PS, Hinckley AF.   +7 more
europepmc   +1 more source